Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 394.00
-1.00 (-0.25%)
Oct 9, 2025, 1:30 PM CST
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 21.46 billion as of October 10, 2025. Its market cap has increased by 41.73% in one year.
Market Cap
21.46B
Enterprise Value
20.37B
Revenue
1.95B
Ranking
n/a
PE Ratio
30.73
Stock Price
394.00
Market Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.46B, an increase of 1,342.99%. That is a compound annual growth rate of 18.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 21.46B | 40.71% |
| Dec 30, 2024 | 15.25B | 37.25% |
| Dec 29, 2023 | 11.11B | 50.00% |
| Dec 30, 2022 | 7.41B | 64.65% |
| Dec 30, 2021 | 4.50B | 2.61% |
| Dec 31, 2020 | 4.38B | 0.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |